Correction: Efficacy and Safety of Filgotinib in Patients with High Risk of Poor Prognosis Who Showed Inadequate Response to MTX: A Post Hoc Analysis of the FINCH 1 Study

Bibliographic Details
Main Authors:	Bernard G. Combe, Yoshiya Tanaka, Maya H. Buch, Peter Nash, Gerd R. Burmester, Alan J. Kivitz, Beatrix Bartok, Alena Pechonkina, Katrina Xia, Kahaku Emoto, Shungo Kano, Thijs K. Hendrikx, Robert B. M. Landewé, Daniel Aletaha
Format:	Article
Language:	English
Published:	Adis, Springer Healthcare 2023-01-01
Series:	Rheumatology and Therapy
Online Access:	https://doi.org/10.1007/s40744-022-00530-0

Internet